1. |
Guiu B, Minello A, Cottet V, et al. A 30-year, population-based study shows improved management and prognosis of hepatocellular carcinoma[J]. Clin Gastroenterol Hepatol, 2010, 8(11):986-991.
|
2. |
Nordenstedt H, White DL, El-Serag HB. The changing pattern of epidemiology in hepatocellular carcinoma[J]. Dig Liver Dis, 2010, 42(Suppl 3):S206-S214.
|
3. |
Jemal A, Bray F, Center MM, et al. Global cancer statistics, 2011[J]. CA Cancer J Clin, 2011, 61(2):69-90.
|
4. |
戴朝六, 赵阳.原发性肝癌的综合治疗[J].中国普外基础与临床杂志, 2014, 21(2):133-137.
|
5. |
许磊波, 王捷, 刘超.不同分期系统对晚期肝癌肝切除患者生存的预测价值比较[J].中国普外基础与临床杂志, 2014, 21(2):138-141.
|
6. |
Moriya S, Morimoto M, Numata K, et al. Fucosylated fraction of alpha-fetoprotein as a serological marker of early hepatocellular carcinoma[J]. Anticancer Res, 2013, 33(3):997-1001.
|
7. |
Ertle JM, Heider D, Wichert M, et al. A combination ofα-feto-protein and des-γ-carboxy prothrombin is superior in detection of hepatocellular carcinoma[J]. Digestion, 2013, 87(2):121-131.
|
8. |
El-Serag HB, Kanwal F.α-Fetoprotein in hepatocellular carcinoma surveillance:mend it but do not end it[J]. Clin Gastroenterol Hepatol, 2013, 11(4):441-443.
|
9. |
Helaly GF, Abou Shamaa LA. Influence of hepatitis C virus infection on circulating levels of sICAM-1 and VEGF in patients with hepatitis C and hepatocellular carcinoma (HCC) and their role in enhancing detection of HCC[J]. Egypt J Immunol, 2006, 13(1):27-38.
|
10. |
Nakano M, Ando E, Kuromatsu R, et al. Recent progress in the management of hepatocellular carcinoma detected during a surveillance program in Japan[J]. Hepatol Res, 2010, 40(10): 989-996.
|
11. |
赵威, 窦科峰, 岳树强, 等.外周血sICAM-1联合AFP检测对原发性肝癌诊断的意义[J].中华实用诊断与治疗杂志, 2008, 22(7):481-482.
|
12. |
Zhu XW, Gong JP. Expression and role of icam-1 in the occurrence and development of hepatocellular carcinoma[J]. Asian Pac J Cancer Prev, 2013, 14(3):1579-1583.
|
13. |
Liu S, Li N, Yu X, et al. Expression of intercellular adhesion molecule 1 by hepatocellular carcinoma stem cells and circulating tumor cells[J]. Gastroenterology, 2013, 144(5):1031-1041.
|
14. |
Zhao YJ, Ju Q, Li GC. Tumor markers for hepatocellular carcinoma[J]. Mol Clin Oncol, 2013, 1(4):593-598.
|
15. |
Wu J, Zou H, Jiang JT, et al. Clinical application of serum alpha-fetoprotein-IgM complexes on the diagnosis of primary hepatocellular carcinoma in Kazakh and Han populations[J]. Tumori, 2013, 99(4):535-539.
|
16. |
Nakazawa T, Hidaka H, Takada J, et al. Early increase inα-fetoprotein for predicting unfavorable clinical outcomes in patients with advanced hepatocellular carcinoma treated with sorafenib[J]. Eur J Gastroenterol Hepatol, 2013, 25(6):683-689.
|
17. |
苏志良, 赵浩亮, 曹燕, 等.大鼠离体肝脏保存再灌注后肝脏中ICAM-1 mRNA的表达及丹参对其表达的影响[J].中国普外基础与临床杂志, 2013, 20(8):932-933.
|
18. |
Long EO. ICAM-1:getting a grip on leukocyte adhesion[J]. J Immunol, 2011, 186(9):5021-5023.
|
19. |
Xiao X, Mruk DD, Cheng CY. Intercellular adhesion molecules (ICAMs) and spermatogenesis[J]. Hum Reprod Update, 2013, 19(2):167-186.
|
20. |
Schmitz V, Sauerbruch T, Raskopf E. Anti-tumoural effects of PlgK1-5 are directly linked to reduced ICAM expression, resulting in hepatoma cell apoptosis[J]. Int J Colorectal Dis, 2012, 27(8): 1029-1038.
|
21. |
Jung CW, Song TJ, Lee KO, et al. Characterization of hepatocellular carcinoma cell lines based on cell adhesion molecules[J]. Int J Mol Med, 2012, 29(6):1158-1164.
|
22. |
Qin LX, Tang ZY. Recent progress in predictive biomarkers for metastatic recurrence of human hepatocellular carcinoma:a review of the literature[J]. J Cancer Res Clin Oncol, 2004, 130(9): 497-513.
|
23. |
Kamezaki S, Kurozawa Y, Iwai N, et al. Serum levels of soluble ICAM-1 and VCAM-1 predict pre-clinical cancer[J]. Eur J Cancer, 2005, 41(15):2355-2359.
|
24. |
Sun JJ, Zhou XD, Zhou G, et al. Expression of intercellular adhesive molecule-1 in liver cancer tissues andliver cancer metastasis[J]. World J Gastroenterol, 1998, 4(3):202-205.
|
25. |
Sarwar S, Khan AA, Tarique S. Validity of alpha fetoprotein for diagnosis of hepatocellular carcinoma in cirrhosis[J]. J Coll Physicians Surg Pak, 2014, 24(1):18-22.
|